MMP9 and prostate cancer: Maslinic acid reduced cell invasion, intercellular adhesion and migration by decreasing the production of vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), matrix metalloproteinase (MMP)-9, MMP-2, intercel-lular adhesion molecule (ICAM), and E-cadherin in human prostate cancer cells [36].